Infobird appoints Yaqing Wei as new CEO, chair

Infobird Co., Ltd (IFBD) reported a leadership change effective August 24, 2026.

Rhea-AI Filing Summary

Infobird Co., Ltd (IFBD) reported a leadership change effective August 24, 2026. Xiangyang Wen resigned as Chief Executive Officer, chairperson of the Board of Directors, and director. On the same date, Yaqing Wei was appointed Chief Executive Officer, Chairperson of the Board, Director, and a member of both the compensation committee and the nomination and governance committee.

The company states that Ms. Wei has prior management and marketing experience at Beijing Aruisite Clinic Co., Ltd and Zhongliang Group China entities, and holds an MBA and a bachelor’s degree from Peking University and California Polytechnic State University. Her employment agreement with Infobird is dated August 24, 2026 and is filed as Exhibit 10.1.

Key Terms

foreign private issuer, compensation committee, nomination and governance committee

3 terms

foreign private issuer regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

compensation committee financial

"a Director, a member of compensation committee, and a member"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

nomination and governance committee financial

"and a member of nomination and governance committee of the Company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership changes did Infobird Co., Ltd (IFBD) announce in this Form 6-K?

Infobird announced that Xiangyang Wen resigned as Chief Executive Officer, chairperson of the Board, and director effective August 24, 2026, and that Yaqing Wei was appointed as Chief Executive Officer, Chairperson of the Board, Director, and committee member on the same date.

What roles will Yaqing Wei hold at Infobird Co., Ltd (IFBD)?

Yaqing Wei will serve as Chief Executive Officer, Chairperson of the Board, a Director, a member of the compensation committee, and a member of the nomination and governance committee of Infobird Co., Ltd.

What is the effective date of the CEO transition at Infobird Co., Ltd (IFBD)?

The CEO transition is effective on August 24, 2026. On that date, Xiangyang Wen resigned from his positions and Yaqing Wei was appointed as Chief Executive Officer, Chairperson of the Board, and Director.

What prior experience does new CEO Yaqing Wei have before joining Infobird (IFBD)?

Since May 2025, Yaqing Wei has been the general manager of Beijing Aruisite Clinic Co., Ltd. From February 2016 to May 2025, she worked in marketing leadership roles at Zhongliang Group China’s Alcohol Business Division and China Foods Co., Ltd.

What are the educational qualifications of Infobird (IFBD) CEO Yaqing Wei?

Yaqing Wei holds a Master of Business Administration and a Bachelor’s Degree in International Marketing / Human Resources and Enterprise Management from Peking University and California Polytechnic State University, obtained in 2025 and 2007, respectively.

Is there an employment agreement between Infobird (IFBD) and Yaqing Wei?

Yes. Infobird states that Ms. Wei has entered into an employment agreement with the company dated August 24, 2026, which is filed as Exhibit 10.1 and is incorporated by reference for additional details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:31 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:30 PM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-40301

Infobird Co., Ltd

(Registrant’s Name)

Room 706, 7/F, Low Block, Grand Millennium Plaza,

181 Queen’s Road Central, Central, Hong Kong

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

When used in this Form 6-K, unless otherwise indicated, the terms “the Company,” “Infobird,” “we,” “us” and “our” refer to Infobird Co., Ltd and its subsidiaries.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

On August 24, 2026, Mr. Xiangyang Wen (“Mr. Wen”) resigned as the chief executive officer, chairperson of the Board of Directors (the “Board”) and director of Infobird Co., Ltd. (the “Company”), immediately effective on August 24, 2026.

On August 24, 2026, Ms. Yaqing Wei (“Ms. Wei”) was appointed as Chief Executive Officer, Chairperson of the Board of Directors, a Director, a member of compensation committee, and a member of nomination and governance committee of the Company.

The biography for Ms. Wei is set forth below:

Yaqing Wei is our Chief Executive Officer, Chairman of the Board, a Director, a member of compensation committee, and a member of nomination and governance committee of the Company. Since May 2025, Ms. Wei has been serving as the general manager of Beijing Aruisite Clinic Co., Ltd  . From February 2016 to May 2025, Ms. Wei served as the director of marketing department of Zhongliang Group China Co., Ltd’s Alcohol Business Division. From July 2019 to August 2021, Ms. Wei served as the deputy director of special channel business unit of Zhongliang Group China Foods Co., Ltd. Ms. Wei received a Master of Business Administration and a Bachelor’s Degree in International Marketing / Human Resources and Enterprise Management from Peking University and California Polytechnic State University in 2025 and 2007, respectively.

Ms. Wei has entered into an employment agreement with the Company, which is filed herewith as Exhibits 10.1, should be reviewed in its entirety for additional information.

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text actual Agreement, which is attached as Exhibit 10.1 to this Current Report and incorporated herein by reference.

Exhibits

Exhibit No		Description
10.1		Employment Agreement between the Registrant and Ms. Yaqing Wei dated August 24, 2026.

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		INFOBIRD CO., LTD
Date: August 25, 2026	By:	/s/ Yaqing Wei
		Yaqing Wei, Chief Executive Officer

Filing Exhibits & Attachments

1 document

Agreements & Contracts

• EX-10.1 EXHIBIT 10.1 7.3 KB